![IPO News by India IPO](assets/images/news/newsimg/theranautilus-secures_img.jpg)
Following a surge in IPO activity post-June's general election, the primary market will see a brief pause next week with no new mainboard issues. However, one SME IPO from Sahaj Solar is set to open on July 11.
Despite the short hiatus, analysts are optimistic about India's strong economic base and promising growth prospects, making it a prime time for the flourishing IPO market.
"India's solid economic foundation and bright growth outlook make it an ideal period for the booming IPO market. We foresee significant investment in public markets and high demand for both innovative and traditional businesses in the near future.
In the first half of the year, 35 companies from various sectors like co-working spaces, furniture retail, and online ticket booking raised nearly ₹32,000 crore," said Mahavir Lunawat, Managing Director of Pantomath Capital Advisors Pvt. Ltd.
Lunawat added, “The second half of CY25 is expected to be stronger for the IPO market, with more activity, potentially larger deals, and new listings across various sectors. Thorough analysis of company fundamentals and future prospects is crucial for investment decisions.”
While no new mainboard IPOs are scheduled, the market will see the listings of Emcure Pharmaceuticals and Bansal Wire, both attracting significant investor interest.
Sahaj Solar IPO : The Sahaj Solar IPO opens on July 11, 2024, and closes on July 15, 2024. This book-built issue aims to raise ₹52.56 crore through 29.2 lakh fresh shares. The price band is set at ₹171 to ₹180 per share. Kunvarji Finstock Pvt Ltd is the lead manager, and Kfin Technologies Limited is the registrar.
Ambey Laboratories IPO : Opened on July 4, 2024, and closing on July 8, 2024, this IPO is a ₹44.68 crore book-built issue with 62.58 lakh fresh shares worth ₹42.55 crore and an offer for sale of 3.12 lakh shares worth ₹2.12 crore. The price band is ₹65 to ₹68 per share. Fast Track Finsec Pvt Ltd is the lead manager, with Link Intime India Private Ltd as the registrar. Nikunj Stock Brokers will be the market maker.
Ganesh Green Bharat IPO Opened on July 5, 2024, and closing on July 9, 2024, this book-built issue aims to raise ₹125.23 crore with 65.91 lakh fresh shares. The price band is ₹181 to ₹190 per share. Hem Securities Limited is the lead manager, Kfin Technologies Limited is the registrar, and Hem Finlease is the market maker.
Effwa Infra and Research IPO Opened on July 5, 2024, and closing on July 9, 2024, this book-built issue amounts to ₹51.27 crore, including 53.17 lakh fresh shares worth ₹43.60 crore and an offer for sale of 9.36 lakh shares worth ₹7.68 crore. The price band is ₹78 to ₹82 per share. Shreni Shares Limited is the lead manager, Bigshare Services Pvt Ltd is the registrar, and Rikhav Securities is the market maker.
Emcure Pharmaceuticals IPO The allotment is expected to be finalized on Monday, July 8, 2024, with the listing on BSE and NSE tentatively set for Wednesday, July 10, 2024.
Bansal Wire IPO The allotment is anticipated to be finalized on Monday, July 8, 2024, with the listing on BSE and NSE tentatively set for Wednesday, July 10, 2024.
Ambey Laboratories IPO The allotment is scheduled for Tuesday, July 9, 2024, with the listing on the NSE SME platform tentatively set for Thursday, July 11, 2024.
Ganesh Green Bharat IPO The allotment is expected to be finalized on Wednesday, July 10, 2024, with the listing on NSE SME tentatively set for Friday, July 12, 2024.
Effwa Infra and Research IPO The allotment is expected to be finalized on Wednesday, July 10, 2024, with the listing on NSE SME tentatively set for Friday, July 12, 2024.